Cited by 1,086Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Open access

Hensley, K, Carney, J M, Mattson, M P, Aksenova, M, Harris, M, Wu, J F, Floyd, R A, Butterfield, D A·1994·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.91.8.3270PMC PMC43558

Open this paper in CoChat — free account

Abstract

beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.91.8.3270

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain.
Oliver, C., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Self-citation
Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.
Carney, J. M., Starke-Reed, P. E., Oliver, C., Landum, R. W., Cheng, M. S., Wu, J., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 724
Self-citation
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
Floyd, R. A., & Carney, J. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320706 · Cited by 539
Self-citation
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I. M., Smith‐Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Self-citation

Show all 23 references

Research works printed but not linked: 5

[9]Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M. & Floyd, R. A. (1990) Proc. Natl. Acad. Sci. USA 87, 5144–5147.
[11]Miller, R. E., Hadenberg, R. & Gersham, H. (1978) Proc. Natl. Acad. Sci. USA 75, 1418–1422.
[13]Janzen, E. G. (1980) in Free Radicals in Biology, ed. Pryor, W. A. (Academic, New York), Vol. 4, pp. 115-154.
[19]Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991) Proc. Natl. Acad. Sci. USA 88, 3633–3636.
[27]Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991) Proc. Natl. Acad. Sci. USA 88, 10540–10543.

Sorted by citations

Items 901–1,000 of 1,000

Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models
Epremyan, K. K., Mamaev, D. V., & Zvyagilskaya, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129791 · Cited by 7
Active Site Environment and Reactivity of Copper‐Aβ in Membrane Mimetic SDS Micellar Environment
Dey, C., Roy, M., Ghosh, R., Pal, P., Roy, D., & Dey, S. G. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202401531 · Cited by 6
Effects of oxidation on redox and cytotoxic properties of copper complex of Aβ1–16 peptide
Ramteke, S., Walke, G. R., Joshi, B. N., Rapole, S., & Kulkarni, P. P. (2014) · Free Radical Research · doi:10.3109/10715762.2014.960412 · Cited by 6
Zinc and Alzheimer's Disease: An Update
Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 6
Arctic Aβ40 blocks the nicotine-induced neuroprotective effect of CHRNA7 by inhibiting the ERK1/2 pathway in human neuroblastoma cells
Ju, Y., Asahi, T., & Sawamura, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.09.005 · Cited by 6
Using a portable total reflection X‐ray fluorescence system for a multielement analysis of Swiss mice brains with experimental Alzheimer's disease induced by β‐amyloid oligomers
Almeida, D. S., Brígido, M. M., Anjos, M. J., Ferreira, S. T., de Souza, A. S., & Lopes, R. T. (2019) · X-Ray Spectrometry · doi:10.1002/xrs.3044 · Cited by 7
Quantitative description of publications (1986-2020) related to Alzheimer disease and oxidative stress: A bibliometric study
Qaid, E. Y. A., Long, I., Azman, K. F., Ahmad, A. H., Othman, Z., Sirajudeen, K. N. S., Ahmi, A., & Zakaria, R. (2021) · Journal of Cellular Neuroscience and Oxidative Stress · doi:10.37212/jcnos.946898 · Cited by 6
Aβ deposition is essential to AD neuropathology
Estus, S., Borchelt, D., Kindy, M. S., & Vassar, R. J. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4302 · Cited by 6
Aβ1-42 peptide toxicity on neuronal cells: A lipidomic study
Davani, L., Fu, X., Simone, A. D., Li, P., Montanari, S., Lämmerhofer, M., & Andrisano, V. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114876 · Cited by 5
Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative
Groechel, R. C., Tripodis, Y., Alosco, M. L., Mez, J., Qiu, W. Q., Mercier, G., Goldstein, L. E., Budson, A. E., Kowall, N. W., & Killiany, R. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.03.005 · Cited by 5
Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo
Kozina, A., Herbert-Alonso, G., Díaz, A., Flores, G., & Guevara, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310258 · Cited by 5
A computational study on the possible role of oxygen in the oxidation of methionine and dimethylsulfide initiated by OH radicals
Xipsiti, C., & Nicolaides, A. V. (2013) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2012.12.020 · Cited by 5
Effect of creatine supplementation on cognitive performance and apoptosis in a rat model of amyloid-beta-induced Alzheimer's disease.
Alimohammadi‐Kamalabadi, M., Eshraghian, M., Zarindast, M., Aliaghaei, A., & Pishva, H. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7814 · Cited by 5
Hyper-acidic fusion minipeptides escort the intrinsic antioxidative ability of the pattern recognition receptor CRP in non-animal organisms
Zhang, M., Liu, Y., Liu, Z., Wang, J., Gong, M., Ge, H., Li, X., Yang, Y., & Zou, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-39388-8 · Cited by 6
β-Amyloid 25–35 Suppresses the Secretory Activity of the Dopaminergic System in the Rat Brain
Mukhin, V. N., Sizov, V. V., Pavlov, K. I., & Клименко, В. М. (2019) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-019-00807-y · Cited by 5
β-Amyloid and Lithium Affect the Magnitude of Phasic Dopamine Release in the Shell of the Nucleus Accumbens
Mukhin, V. N., Borovets, I. R., Sizov, V. V., Pavlov, K. I., & Клименко, В. М. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01058-6 · Cited by 5
Chapter 14 – Oxidative Stress and Neuroinflammation in Alzheimer's Disease and Amyotrophic Lateral Sclerosis: From Biology to Therapeutic Strategies
Mhatre, M., & Hensley, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50155-1 · Cited by 4
Self-citation
Chapter 1 Structure and Functions of Biomembranes
(2008) · Current topics in membranes · doi:10.1016/s1063-5823(08)00201-9 · Cited by 5
Exaggerated polymerisation of ?-amyloid 40 stimulated by plasma lipoproteins results in fibrillar A? preparations that are ineffective in promoting ADP-induced platelet aggregation
Stanyer, L., Betteridge, D. J., & Smith, C. C. T. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.07.005 · Cited by 5
Enhanced Cholinergic Function in Aged Rats Treated with TJ-23
Hiramatsu, M., Komatsu, M., Yuzurihara, T., SAITOH, K., Ishige, A., & KOMATSU, Y. (1999) · Rejuvenation Research · doi:10.1089/rej.1.1999.2.51 · Cited by 5
Aluminum-Induced Conformational Changes of .BETA.-Amyloid Protein and the Pathogenesis of Alzheimer's Disease
Kawahara, M. (2003) · Eisei kagaku · doi:10.1248/jhs.49.341 · Cited by 5
Alzheimer’s β-Amyloid Peptide and Free Radical Oxidative Stress
Butterfield, D. A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46806-9_25 · Cited by 5
Self-citation
Toxic Levels of Amyloid Beta Peptide Do Not Induce VEGF Synthesis
Park, S.-Y., & Chae, C. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)10757-6 · Cited by 5
Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals
Mattson, M. P. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50025-1 · Cited by 5
Self-citation
Active Oxygen Species Formation in Synaptosomes Exposed to an Aluminum Chelator
Bondy, S. C., Tseng, H., & Orvig, C. (1998) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(97)00103-7 · Cited by 5
Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease
Kumar, V., Goldstein, M. Z., & Doraiswamy, P. M. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.249 · Cited by 5
Clinical Potential of Agents That Affect Thrombin Signaling in Degenerative and Traumatic Neurologic Disorders
Festoff, B. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-475-7_12 · Cited by 5
Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-β
Bi, D., Gao, B., Shen, Y., Dai, Z., Yang, S., & Wang, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149873 · Cited by 4
Polystyrene nanoplastic exposure promotes amyloid misfolding and metabolic impairment at sublethal doses. A subcellular infrared imaging study
Silva, I. A. N., Paulus, A., Skoryk, V. R., Su, K.-Y., Herranz-Trillo, F., & Klementieva, O. L. (2026) · Environmental Science Nano · doi:10.1039/d5en01181g · Cited by 4
N⁴ Sim: The First Nervous NaNoNetwork Simulator With Synaptic Molecular Communications
Turgut, N. A., Bilgin, B. A., & Akan, Ö. B. (2021) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2021.3118851 · Cited by 4
Rapid autoxidation of ferrous heme-Aβ complexes relevant to Alzheimer's disease
Roy, M., Dey, A., & Dey, S. G. (2024) · Chemical Communications · doi:10.1039/d3cc05025d · Cited by 4
New Free Radicals to Measure Antiradical Capacity: A Theoretical Study
León‐Carmona, J. R., Martínez, A., & Galano, A. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp505586k · Cited by 4
Current approaches and future directions of gene therapy in Alzheimer’s disease
Stepanichev, M. Y. (2011) · Neurochemical Journal · doi:10.1134/s181971241103010x · Cited by 4
Workflow and Methods of High-Content Time-Lapse Analysis for Quantifying Intracellular Calcium Signals
Li, F., Zhou, X., Zhu, J., Xia, W., Ma, J., & Wong, S. T. C. (2008) · Neuroinformatics · doi:10.1007/s12021-008-9016-z · Cited by 4
Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease
Zhu, X., Perry, G. L., & Smith, M. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_19 · Cited by 4
Role of Copper and Other Transition Metal Ions in the Pathogenesis of Parkinson's Disease, Prion Diseases, Familial Amyotrophic Lateral Sclerosis, and Alzheimer's Disease
Multhaup, G., Dieter, H. H., Beyreuther, K. T., & Bayer, T. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-288-3_17 · Cited by 4
β-amyloid-Derived Free Radical Oxidation
Butterfield, D. A., Hensley, K., Hall, N. C., Ramachandran, S., Howard, B. J., Cole, P. S., Yatin, S. M., LaFontaine, M., Harris‐White, M. E., Aksenova, M. V., et al. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_9 · Cited by 4
Self-citation
Commentary: Proteooxidotoxic Process of Aggregation
Mattson, M. P. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8146-x · Cited by 4
Self-citation
Oncogenic parallels in Alzheimer disease
Raina, A. K., Garrett, M. R., Previll, L. A., Obrenovich, M. E., Hartzler, A., Webber, K. M., Casadesús, G., Lee, H., Perry, G. L., Zhu, X., et al. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 4
Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer’s Disease
Arora, R., Babbar, R., Dabra, A., Chopra, B., Deswal, G., & Grewal, A. S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249269050231129103002 · Cited by 3
Role of phytochemicals isolated from Cirsium japonicum in neurological disorders
Yao, L., Javed, A., Nisar, M. F., & Wan, C. C. (2024) · Phytonutrients · doi:10.62368/pn.v1i01.16 · Cited by 3
Formation of Methionine Sulfoxide of Amyloid β‐Peptide (1‐40) by Cu(bdpe)/H2O2 System
Kishita, A., Nishino, S., Togashi, T., & Nishida, Y. (2005) · Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry · doi:10.1080/15533170500301820 · Cited by 3
Effects of NK-4, a Cyanine Dye with Antioxidant Activities: Attenuation of Neuronal Deficits in Animal Models of Oxidative Stress-Mediated Brain Ischemia and Neurodegenerative Diseases
Ohta, H., Akita, K., & Oht, T. (2012) · InTech eBooks · doi:10.5772/34943 · Cited by 3
Protective Effect of Anthocyanin Against The Oxidative Stress in Neuroblastoma N2a Cells*
Liu, L., Sheng, B., Yan, Y., Gong, K., Ma, T., Zhao, N., Zhang, X., & Gong, Y. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00773 · Cited by 3
Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms
Su, K., Wen, T., Chou, C., Chang, G., Liu, G., & Hung, H. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21443 · Cited by 3
Neuronal cell protective effect of aerial parts of Chinese lizard’s tail (Saururus chinensis (Lour.) Baill.)
Jeong, H. R., Jeong, C., Kwak, J. H., Kim, J. H., Lee, U., Choi, G. N., Choi, S., & Heo, H. J. (2011) · Food Science and Biotechnology · doi:10.1007/s10068-011-0118-2 · Cited by 3
Metales de transición y enfermedad de Alzheimer
Opazo, C. (2005) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(05)74885-x · Cited by 3
Strategies to delay the onset of Alzheimer’s disease
Hüll, M. H., Fiebich, B. L., & Lieb, K. (2000) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-8393-1_13 · Cited by 3
The Impact of HAART on Advanced Brain Aging: Implications for Mitochondrial Dysfunction and APP Processing
Campos, J. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.s10-003 · Cited by 3
From Kinetics of OH Reaction with Glutamic Acid to Oxidative Damage to Proteins
Keshavarz, F., & Mazarei, E. (2018) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.8b08664 · Cited by 3
Lebensdauer: Genetische Determinierung und lebensverlängernde Strategien
Niedermüller, H., & Hofecker, G. (2004) · Springer eBooks · doi:10.1007/978-3-642-18741-4_2 · Cited by 3
Aβ 42 oligomers impair the bioenergetic activity in hippocampal synaptosomes derived from APP-KO mice
Beckert, B., Acker‐Palmer, A., & Volknandt, W. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0238 · Cited by 3
Oxygen Radical-Mediated Oxidation of Serotonin: Potential Relationship to Neurodegenerative Diseases
Wrona, M. Z., Yang, Z., Waśkiewicz, J., & Dryhurst, G. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_35 · Cited by 3
Putative Links Between Some of the Key Pathological Features of the Alzheimer's Brain
Quirion, R., Auld, D. S., Beffert, U., Poirier, J., & Kar, S. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50014-2 · Cited by 3
Apolipoprotein E Oxidation and Functional Consequences
Leininger‐Muller, B., Jolivalt, C. G., Pillot, T., Lagrange, P., Livertoux, M.-H., Grassiot, M.-C., Minn, A., & Siest, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_14 · Cited by 3
Neurotoxicity of environmental pollutants
Al‐Mousa, F. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
The Role of Oxidative Stress in the Pathological Sequelae of Alzheimer Disease
Smith, M. A., & Perry, G. L. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2907-8_19 · Cited by 3
Nanoparticles for the Treatment of A lzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0122 · Cited by 3
Treatment Development Strategies for Alzheimer's Disease
Wülfert, E. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00300.x · Cited by 3
The impact of genetic and environmental factors on the pathobiology of Alzheimer's disease: a multifactorial disorder?
Harrington, C. R., & Wischik, C. M. (1995) · International Review of Psychiatry · doi:10.3109/09540269509022988 · Cited by 3
Update on the Development of Medication for Memory and Cognition in Alzheimer's Disease
Kumar, V., & Cantillon, M. (1996) · Psychiatric Annals · doi:10.3928/0048-5713-19960501-09 · Cited by 3
Arbutin attenuates aluminium chloride–induced neurotoxicity and cognitive deficits in a zebrafish model of Alzheimer’s disease
Uvarajan, D., Ravikumar, M., & Durairaj, B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04612-y · Cited by 2
Innovative public-health strategies for neurodegenerative disease: leveraging diversified ultraviolet irradiation as a next-generation therapy
Khan, M., Saeed, U., Piracha, Z. Z., Özsahin, İ., & Shao-Chun, C. (2025) · Brazilian Journal of Biology · doi:10.1590/1519-6984.297765 · Cited by 3
Influence of Bilberry Extract on Neuronal Cell Toxicity
König, S., Bakuradze, T., Jesser, S., Sreeja, H. A., Carlsson, M. J., Fahrer, J., Kins, S., & Richling, E. (2024) · Biology · doi:10.3390/biology13060376 · Cited by 3
The protective effects of melatonin against electromagnetic waves of cell phones in animal models: A systematic review
Amiri, M. M., Khazaie, H., & Mohammadi, M. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12552 · Cited by 2
7,8-dithydroxycoumarins protect human neuroblastoma cells from Aβ- mediated neurotoxic damage via inhibiting JNK and p38MAPK pathways.
Liu, G., Xu, K., Li, J., & Luo, Y. (2016) · Biomedical Research-tokyo · Cited by 2
From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
Zheng, H., Amit, T., Bar‐Am, O., Fridkin, M., Mandel, S. A., & Youdim, M. B. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_234 · Cited by 2
Action and Interaction of Amyloid-β and Insulin on Dopamine Release and Reuptake in the Dorsal Lateral Striatum of Rats
Mukhin, V. N., Borovets, I. R., Sizov, V. V., & Клименко, В. М. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024010125 · Cited by 2
Enhancing amyloid beta inhibition and disintegration by natural compounds: A study utilizing spectroscopy, microscopy and cell biology
Pariary, R., Shome, G., Dutta, T., Roy, A., Misra, A. K., Jana, K., Rastogi, S., Senapati, D., Mandal, A. K., & Bhunia, A. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107291 · Cited by 2
Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders
Keller, J. N., & Glazner, G. W. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)07020-1 · Cited by 2
The Use of Gpx4 Knockout Mice and Transgenic Mice to Study the Roles of Lipid Peroxidation in Diseases and Aging
Ran, Q., & Liang, H. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_12 · Cited by 2
Re-mention of an old neurodegenerative disease: Alzheimer’s disease
Zhang, P., Adams, U., & Yuan, Z. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5673-x · Cited by 2
Oxidative stress modulation in neurodegenerative diseases
Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0053-z · Cited by 2
Human Fetal Brain Cell Culture
Mattson, M. P. (2004) · Humana Press eBooks · doi:10.1385/1-59259-861-7:163 · Cited by 2
Self-citation
Role of Nutritional Antioxidants in the Prevention and Treatment of Neurodegenerative Disorders
Esposito, E. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch5 · Cited by 2
Protein Aging and Its Relevance to the Etiology of Alzheimer’s Disease
Stadtman, E. R. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_11 · Cited by 2
Cellular and Molecular Mechanisms Underlying Synaptic Degeneration and Neuronal Death in Alzheimer's Disease
Mattson, M. P., Pedersen, W. A., & Culmsee, C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_6 · Cited by 2
Self-citation
Neurodegenerative Disease and Oxidative Stress: Insights from an Animal Model of Parkinsonism
Hastings, T. G., & Zigmond, M. J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_6 · Cited by 2
Oxidative Stress and Mitochondrial Dysfunction in Neurodegeneration of Transmissible Spongiform Encephalopathies (TSEs)
Kim, B., Kim, J.-I., Carp, R. I., & Kim, Y. (2005) · Springer eBooks · doi:10.1007/0-387-23923-5_8 · Cited by 2
Mitochondrial ROS Production Initiates Aβ1-40-Mediated Up-Regulation of L-Type Ca2+ Channels during Chronic Hypoxia
Fearon, I. M., Brown, S. T., Hudasek, K., Scragg, J. L., Boyle, J. P., & Peers, C. (2006) · Springer eBooks · doi:10.1007/0-387-31311-7_30 · Cited by 2
Amyloid Toxicity, Synaptic Dysfunction, and the Biochemistry of Neurodegeneration in Alzheimer’s Disease
Ng, J., Aguilar, M., & Small, D. H. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_6 · Cited by 2
From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
Zheng, H., Amit, T., Bar‐Am, O., Fridkin, M., Mandel, S. A., & Youdim, M. B. H. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_234-1 · Cited by 2
Neuroprotection and Neuroregeneration in Alzheimer's Disease
Sugaya, K., Youdim, M. B. H., Nordberg, A. K., & Rao, K. S. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/864138 · Cited by 2
In Vivo Ribozyme Targeting of βAPP+ mRNAs
Dolzhanskaya, N., Conti, J., Merz, G., & Denman, R. B. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2001.0287 · Cited by 2
Neurotoxic Oxidative Metabolite of Serotonin
Volicer, L., Wrona, M. Z., Matson, W. R., & Dryhurst, G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_8 · Cited by 2
Vitamin E
Vatassery, G. T. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_10 · Cited by 2
Reduction
Kammermeier, B. (2000) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a22_687 · Cited by 2
[Wine and health: recent findings].
Berke, B., Vauzour, D., Castagnino, C., Arnaudinaud, V., Nay, B., Chèze, C., & Vercauteren, J. (2003) · PubMed · Cited by 2
In Vivo Imaging of Alzheimer Pathology in Transgenic Mice using Multiphoton Microscopy
Bacskai, B. J., Klunk, W. E., Hickey, G. A., Skoch, J. M., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., et al. (2004) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-59300-0_4 · Cited by 2
Evaluation of Storage Conditions for Assessing DNA Damage Using the Comet Assay
Villavicencio, D. (2006) · IUScholarWorks (Indiana University) · doi:10.7912/c2/278 · Cited by 2
Signaling by β-Amyloid Precursor Protein
Furukawa, K. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-475-7_11 · Cited by 2
Role of Antioxidants in Coronary Artery Disease
Mason, R. P. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-001-8_3 · Cited by 1
Neuroprotective actions of hydroxytyrosol
Yeste, N., Gonzalez‐Bulnes, A., Bassols, A., & Pérez‐Valle, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00042-7 · Cited by 1
Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease
Joseph, J. A., Casadesús, G., Smith, M. A., Perry, G. L., & Shukitt‐Hale, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00020-2 · Cited by 1
[The scavenger receptor and its importance in amyloid processes].
Aguilar-Gaytán, R., & Mas‐Oliva, J. (2002) · PubMed · Cited by 1
Neurotoxicity of the Alzheimer’s β-Amyloid Peptide
Howlett, D. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_6 · Cited by 1
β-amyloid(25-35) inhibits the activity of inositol (1,4,5)-trisphosphate-5-phosphatase
Rönnbäck, A., & Fowler, C. J. (2000) · Amyloid · doi:10.3109/13506120009146244 · Cited by 1
The Drug Development Based on Pathogenetic Research in Alzheimer’s Disease
Lin, X., & Zhang, Q. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.32007 · Cited by 1
Is the A-beta peptide of Alzheimer’s Disease an Antimicrobial Peptide?
Johnstone, D. M. (2014) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000165 · Cited by 1
Untitled work
Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Authors: Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A.
Affiliations: University of Kentucky (US)
Department of Chemistry, University of Kentucky, Lexington 40506.
ORCID: Mattson, M P
Aksenova, M
Butterfield, D A
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1994-04-12
Volume: 91
Issue: 8
Pages: 3270-3274
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.91.8.3270
PMC: PMC43558
OpenAlex: W2070117026
Cited by: 1,086
References: 23
Citations by year: 2026: 6 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 23 · 2015: 27 · 2014: 26 · 2013: 32 · 2012: 34
FWCI: 35.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (9108764)
Glenn Foundation for Medical Research
Fondation pour la Recherche Médicale
National Institutes of Health (AG-10836)
National Institute on Aging (AG 09690, P01AG010836, R01AG009690, AG 10836)
Office of Naval Research
National Institute of Neurological Disorders and Stroke (R01NS023307, NS-23307)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, amyloid fibril formation, neurotoxicity, free radicals, reactive oxygen species, glutamine synthetase, creatine kinase, salicylate hydroxylation, amyloid plaques, Alzheimer's disease, peptide fragmentation, membrane alterations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Chromatography, High Pressure Liquid, Electron Spin Resonance Spectroscopy, Free Radicals, Gas Chromatography-Mass Spectrometry, Molecular Sequence Data, Neurotoxins, Salicylates, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks